Global Trends in the Use of Insecticides to Control Vector-Borne Diseases by van den Berg, Henk et al.
Environmental Health Perspectives  •  v o l u m e  120 | n u m b e r 4 | April 2012  577
Research
Vector control constitutes an important 
element in the current global strategies for the 
control of major vector-borne diseases, notably 
malaria, dengue, leishmaniasis, and Chagas 
disease (Townson et al. 2005). Since the 
advent of DDT (dichlorodiphenyltrichloro-
ethane) and other organochlorine insecticides 
in the 1940s, vector control has depended 
largely on the action of chemical insecticides to 
kill vectors or prevent transmission of disease 
pathogens to humans. In recent years, vector 
control interventions in which insecticides are 
used to control malaria have been scaled up 
in many countries, resulting in considerable 
reductions in disease morbidity and mortality 
[World Health Organization (WHO) 2010a].
Against these positive outcomes, a recent 
global survey among countries at risk for 
vector-borne diseases drew attention to critical 
deficiencies in the capacity to manage vector 
control insecticides. Deficiencies included the 
lack of guidelines for pesticide registration, 
gaps in pesticide procurement practices, 
and a lack of training of vector control 
decision makers (Matthews et al. 2011; van 
den Berg et al. 2011). These shortcomings 
could hamper the optimal selection and use 
of insecticides and application methods for 
vector control, undermining the effectiveness 
and safety of operations.
The extensive use of vector control 
insecticides has raised concern over the 
develop  ment of insecticide resistance and 
adverse effects on the environment and human 
health. Genes conferring insecticide resistance 
have been spreading in vector populations, 
particularly in vectors of pathogens causing 
malaria and dengue (Ranson et al. 2010, 
2011). Recent monitoring data on malaria 
vectors in Africa confirm that levels of 
resistance are increasing, especially against 
pyrethroid insecticides, and that resistance is 
being recorded in new locations (Butler 2011). 
Pyrethroids are currently the only class of 
insecticides approved for treating netting fabric 
because of their rapid effects on mosquitoes at 
low dosages combined with their relatively low 
health risk (Zaim et al. 2000). Factory-made 
long-lasting insecticidal nets (LNs) currently 
are a key malaria control tool; thus, the 
effectiveness of pyrethroids must be preserved 
for as long as possible (WHO 2011a).
The Stockholm Convention on Persistent 
Organic Pollutants (2012) emphasized the 
need for alternatives to the use of the organo-
chlorine compound DDT in vector control, 
given its toxicity, environmental persistence, 
bioaccumulation, and potential for trans-
boundary movements. Until locally appropri-
ate and cost-effective alternatives are available 
for a sustainable transition from DDT, WHO 
(2007) recommends using it for indoor resid-
ual spraying, according to their guidelines and 
recommendations and those of the Stockholm 
Convention (2012), and using best practices to 
protect spray workers and residents in treated 
households from exposure (WHO 2011b).
The goals of this study were to provide a 
comprehensive assessment of global use pat-
terns of vector control insecticides, to deter-
mine whether trends in the use of pyrethroids 
(for applications other than LNs) are consis-
tent with the need to preserve the effective-
ness of LNs in areas where they are widely 
deployed, and to determine if the global use 
of organochlorines for vector control has 
changed since the Stockholm Convention 
went into effect in 2004. We limited the 
scope of our analysis to insecticides used 
against vectors of pathogens that cause human 
disease. In addition, we included insecticides 
used to (re)treat nets or curtains but excluded 
insecticides used in the manufacture of LNs.
Materials and Methods
Data collection. We asked countries to pro-
vide national data on insecticide use for vec-
tor control using a standard reporting format 
(WHO 2011c) to obtain data on insecticide 
compound and class, formulation and concen-
tration, type of application, disease targeted or 
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purpose of use, and the amount of formulation 
used during each year. We converted quantita-
tive data on insecticide formulations to the 
amount of the active ingredient in each formu-
lation for comparative purposes.
In October 2010, we sent the survey to 
the WHO regional offices for Africa, the 
Americas (South and North America), the 
Eastern Mediterranean, Europe, South-East 
Asia, and the Western Pacific.
These offices in turn distributed the survey 
to WHO country offices in member states, 
specifically their focal points for malaria and 
other vector-borne diseases, that worked 
through ministries of health to facilitate data 
collection and validation.
Member states targeted for this study were 
those with vector control programs in place. 
Territories or special areas that are the respon-
sibility of other member states were excluded 
from the survey. In total, 143 countries were 
selected, representing a human popu  lation of 
5.49 billion. The survey excluded Australia, 
Japan, Canada, and the United States, and 
targeted countries in the European region 
were limited to Armenia, Azerbaijan, Georgia, 
Kyrgyzstan, Tajikistan, Turkey, Turkmenistan, 
and Uzbekistan. However, because some of the 
excluded countries use insecticides for vector 
control, for example, against West Nile virus 
in North America (Kramer et al. 2008), these 
countries should be considered for inclusion in 
future studies.
Countries were asked for insecticide use 
data for 2008 and 2009 and to provide miss-
ing or updated data, where appropriate, for 
the years 2000 through 2007. The data were 
supplemented with data previously reported 
to the WHO using the same format and 
reporting system.
Insecticide application methods. We classi-
fied the reported methods of application of 
vector control insecticides as residual spraying, 
space spraying, treatment of nets, and larvi-
ciding (WHO 2006). Residual spraying refers 
to the spraying of interior surfaces of houses 
targeting indoor resting vectors (or indoor 
residual spraying), and “perifocal treatment” of 
larval habitats and peripheral mosquito resting 
surfaces for dengue control (WHO 2009a). 
Treatment of nets refers to the conventional 
application of insecticides to treat bed nets or 
curtains (excluding the use of insecticides in 
factory manufacturing of LNs). Larviciding 
refers to the use of insecticides to treat aquatic 
breeding sites of mosquitoes.
Miscellaneous application methods reported   
by some countries but excluded from the 
analysis were dusting treatment against plague 
(1.4% of total use) and the use of insecticidal 
paints (0.1% of total pesticide use).
We quantified the insecticide application 
rate for residual spraying as the amount of 
active ingredient per square meter. We distin-
guished between two categories of insecticides: 
organochlorines, organophosphates, and car-
bamates, for which the recommended appli-
cation rate for residual spraying is generally 
around 1.5 g/m2 (although there are excep-
tions, for example, the carbamate bendiocarb, 
with a recommended rate of 0.1–0.4 g/m2) 
(Najera and Zaim 2002), and pyrethroids, 
which have a recommended application rate of 
around 0.025 g/m2, 1/60th of the amount of 
the first category. A similar conversion factor 
applies to insecticides commonly used in space 
spraying, which are quantified as the amount 
of active ingredient applied per hectare (Najera 
and Zaim 2002). Hence, the “spray utility,” 
defined here as the recommended surface or 
area covered by a given amount of active ingre-
dient, was approximately 60 times higher for 
pyrethroids than for organochlorines, organo-
phosphates, and carbamates.
Data analysis. We conducted analyses of 
the 10-year average data and of annual trends. 
We assumed that a report by a country for a 
particular year covered all insecticide uses for 
vector control during that year. If a coun-
try failed to report for a particular year, we 
treated the data as missing for that country 
and year.
For each country, we determined the 
10-year average use by averaging the use for 
all reported years, excluding years with miss-
ing data. Data from all responding countries 
were totaled to produce a global estimate.
The rate of reporting increased gradually, 
from 78 countries in 2000 to 92 countries 
in 2009. Therefore, we weighted the data 
to estimate the global annual use. For each 
year, we determined the combined human 
population of the responding countries 
using WHO health statistics (WHO 2010b) 
and divided the resulting value by the total 
population of all 143 targeted countries 
to derive a weighting factor based on the 
proportion of the targeted population with 
available data. Subsequently, we divided 
the reported annual insecticide use by the 
weighting factor to estimate the global 
annual insecticide use for vector control. The 
weighting factor ranged from 0.81 to 0.91.
We calculated the intensity of insecticide 
use, expressed in the amount of active ingre-
dient used per capita per year, as a measure 
of per-capita expenditure or potential human 
exposure within each WHO region.
Data on the four main disease targets for 
vector control insecticides—malaria, dengue, 
leishmaniasis, and Chagas disease—were sub-
mitted to separate analysis. Some countries 
reported that insecticide application methods 
were targeted at more than one disease. This 
mixed-purpose use of insecticides, which con-
stituted 2% of the global use of organophos-
phates and 3% of global use of pyrethroids, 
was included in the assessment of insecticide 
use per disease.
Results
Country responses. Of the 143 countries 
targeted, insecticide use data were provided 
by 125 countries (87%), representing 
97% of the total population of all targeted 
countries (Table 1). Countries varied in 
their consistency of annual reporting, but 
43 countries representing a human population 
of 3.88 billion submitted all 10 annual 
reports. A complete list of responding 
countries and details regarding annual 
reporting are provided in Supplemental 
Material, Table 1 (http://dx.doi.org/10.1289/
ehp.1104340).
Global use. Malaria was the primary disease 
target for vector control insecticides, followed 
by dengue, leishmaniasis, and Chagas disease 
(endemic to Latin America). Organochlorines 
and carbamates were used for residual spraying; 
organophosphates were used for residual 
spraying, space spraying, and larviciding; and 
pyrethroids were used for residual spraying, 
space spraying, and treatment of nets. Space 
spraying was common only in the American 
and Western Pacific WHO regions. Very 
similar amounts of insecticides were used for 
Table 1. Countries and their representative populations that were targeted and responded to the data 
reporting request according to WHO region.a
No. of countries
  Respondedb 2008 population (×106)c
WHO region Targetedd
1–4 
reports
5–9 
reports
10 
reports
Total 
n (%) Targeted
No. responded 
(%)
Africa 46 19 12 6 37 (80) 805 680 (85)
Americas 32 11 13 8 32 (100) 570 570 (100)
Eastern Mediterranean 21 3 6 9 18 (86) 580 562 (97)
Europe 8 1 0 7 8 (100) 135 135 (100)
South-East Asia 11 1 3 6 10 (91) 1,760 1,737 (99)
Western Pacific 25 7 6 7 20 (80) 1,639 1,629 (99)
All 143 42 40 43 125 (87) 5,489 5,314 (97)
aDetails on the populations of, and reporting by, individual countries are available in Supplemental Material, Table 1 
(http://dx.doi.org/10.1289/ehp.1104340). bCountries that responded with 1–4, 5–9, or 10 annual reports over the 10-year 
period, 2000–2009. cData from WHO (2010b). dCanada and the United States (Americas region) and Australia and Japan 
(Western Pacific region) were not targeted, whereas in the European region, only Armenia, Azerbaijan, Georgia, 
Kyrgyzstan, Tajikistan, Turkey, Turkmenistan, and Uzbekistan were targeted. Vector control insecticide use
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space spraying against malaria and dengue, 
which is of concern because space spraying 
has rather limited indications for malaria 
control (Najera and Zaim 2002). Additional 
information on the major insecticide 
compounds used in the control of malaria 
and dengue is provided in Supplemental 
Material, Table 2 (http://dx.doi.org/10.1289/
ehp.1104340).
DDT, the only organochlorine reported, 
was used in higher quantities than any other 
insecticide class and was exclusively applied 
in indoor residual spraying (Table 2). Of 
the global use of DDT, 82% was in India 
alone; the remainder was used in Africa, with 
Ethiopia contributing 11.3%, Mozambique 
2.2%, Namibia 1.3%, South Africa 1.2%, 
and Zimbabwe, Zambia, Madagascar, Eritrea, 
Swaziland, Uganda, and Mauritius each 
< 1% of the global use. Organophosphates 
were used in residual spraying, space spraying, 
and larviciding. The use of carbamates, which 
was predominantly in the African region, 
was small compared with other classes of 
insecticides. Pyrethroids did not constitute 
a major global share in terms of metric tons 
applied but accounted for 81% of the global 
spray utility (the surface area covered by an 
active ingredient). Sixty-eight percent of 
pyrethroids was used for residual spraying, and 
24% for space spraying. The American region 
accounted for 56% of the global amount of 
pyrethroids used for vector control.
Organochlorines were used at an intensity 
of 1.18 and 2.09 g per capita per year in the 
African region and South-East Asian region, 
respectively. Organophosphate use was most 
intensive in the American region, at 0.80 g 
per capita, followed by the South-East Asian 
region, at 0.33 g per capita. Pyrethroid use 
was most intensive by far in the American 
region, at 0.40 g per capita, followed by the 
African region and Western Pacific region, 
each at 0.05 g per capita.
In addition to the main classes of 
insecticides, some countries reported the use 
of bacterial larvicides (WHO 2011c). Bacillus 
thuringiensis israelensis was reported mainly for 
dengue control, with a global use of 70–300 
metric tons of formulated product per year. 
Bacillus sphaericus was reported exclusively 
against malaria at an increasing trend with 
200–300 metric tons of formulated product 
in recent years. The reported global use of 
insect growth regulators was around 3 metric 
tons of active ingredient per year.
Individual diseases. Eighty-one percent 
of organochlorines (i.e., DDT) was used 
against malaria (Table 3); the remainder 
was used for leishmaniasis control in India. 
Organophosphates and pyrethroids were 
used mainly against malaria and dengue, and 
carbamates were used mainly against malaria. 
Diseases reportedly targeted with pyrethroids 
were, foremost, malaria and dengue, followed 
by Chagas disease, leishmaniasis, gastrointestinal 
diseases, and lymphatic filariasis.
Trends. The annual data show that 
global use of the organochlorine DDT has 
been high, without a clear trend [Table 4; 
for use by region and disease, respectively, 
see Supplemental Material, Tables 3 and 4 
(http://dx.doi.org/10.1289/ehp.1104340)]. 
Organophosphate use showed a major decline 
in 2001 after extensive use during the 1990s, 
especially in India (WHO 2009b). Carbamate 
use in indoor residual spraying increased in 
recent years. Pyrethroid use peaked sharply 
in 2002 and increased gradually in recent 
years because of increased use in residual 
Table 2. Average reported insecticide use for vector control according to method of application and 
class of insecticide by WHO region (2000–2009), in metric tons of active ingredient per year.
Residual spraying Space spraying Treatment  
of nets (PY)b
Larvicidingc
WHO regiona OC OP C PY OP PY OP PY
Africa 805 19 19 24 0 0 12 1 0
Americas 0 97 4 164 276 66 0 82 0
Eastern Mediterranean 0 26 5 15 2 5 1 20 1
Europe 0 2 0 1 0 1 0 1 0
South-East Asia 3,623 483 2 39 15 1 4 49 0
Western Pacific 0 1 0 39 292 27 14 9 0
All 4,429 627 30 282 584 100 31  163 2
Abbreviations: C, carbamates; OC, organochlorines (DDT only); OP, organophosphates; PY, pyrethroids.
aCanada and the United States (Americas region) and Australia and Japan (Western Pacific region) were not targeted, 
whereas in the European region, only Armenia, Azerbaijan, Georgia, Kyrgyzstan, Tajikistan, Turkey, Turkmenistan, and 
Uzbekistan were targeted. bConventional application of insecticides to treat bed nets or curtains (excluding insecticides 
used in factory-made LNs). cThe use of insecticides to treat aquatic breeding sites of mosquitoes. 
Table 3. Average reported insecticide use for vector control according to method of application and 
class of insecticide by disease (2000–2009), in metric tons of active ingredient per year.
Residual spraying Space spraying Treatment  
of nets (PY)a
Larvicidingb
Disease OC OP C PY OP PY OP PY
Malaria 3,604 589 26 130 286 11 31 60 0
Malaria and dengue 0 3 0 5 11 33 0 2 0
Malaria and otherc 0 11 0 4 0 0 0 0 0
Dengue 0 7 1 61 235 34 0 81 0
Dengue and otherd 0 0 0 0 51 21 0 3 0
Leishmaniasis 825 1 1 20 0 0 0 0 0
Chagas disease 0 5 1 35 0 0 0 0 0
Lymphatic filariasis 0 3 0 1 0 0 0 13 0
Gastrointestinal disease 0 7 0 3 1 0 0 1 0
Bartonellosis 0 2 0 0 0 0 0 0 0
Unspecified 0 1 0 22 0 1 0 2 1
Abbreviations: C, carbamates; OC, organochlorines (DDT only); OP, organophosphates; PY, pyrethroids. 
aConventional application of insecticides to treat bed nets or curtains (excluding insecticides used in factory-made LNs). 
bThe use of insecticides to treat aquatic breeding sites of mosquitoes. cMalaria plus leishmaniasis or Chagas disease. 
dDengue and other arboviral diseases.
Table 4. Average reported insecticide use for vector control according to method of application and 
class of insecticide by year (2000–2009), in metric tons of active ingredient.
Application/insecticide class 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009
Residual spraying
OC 3,512 5,305 4,814 5,693 5,745 6,065 4,436 4,558 6,170 5,127
OP 5,126 293 135 65 42 115 362 684 145 230
C 12 5 7 8 11 19 18 33 49 30
PY 124 200 1,374 184 153 137 166 176 155 261
Space spraying
OP 840 398 934 502 755 875 405 388 284 238
PY 62 71 70 53 54 83 47 111 210 193
Treatment of nets (PY) 58 23 18 29 7 43 11 29 38 14
Larviciding
OP 297 180 219 108 188 169 206 221 106 118
PY 1 1 0 0 0 1 6 6 0 0
All
OC 3,512 5,305 4,814 5,693 5,745 6,065 4,436 4,558 6,170 5,127
OP 6,263 871 1,288 675 985 1,159 973 1,293 536 585
C 12 5 7 8 11 19 18 33 49 32
PY 245 295 1,462 266 214 264 230 321 403 468
Abbreviations: C, carbamates; OC, organochlorines (DDT only); OP, organophosphates; PY, pyrethroids.van den Berg et al.
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spraying and space spraying. The 2002 peak 
in pyrethroids was attributable to residual 
spraying against malaria, dengue, Chagas 
disease, and leishmaniasis in Brazil that year. 
The contribution of pyrethroids to global 
insecticide use for vector control in terms of 
spray utility increased from 60% in year 2000 
to 83% in 2009 (Figure 1).
Trends in vector control insecticide use 
were most marked in the African region. The 
use of organochlorines (i.e., DDT) increased 
steadily, peaked in 2008, and dropped in 
2009 (Figure 2). The 2009 decline in DDT 
use was accompanied by an increase in the use 
of pyrethroids. In India, use of DDT showed 
a decline from 5,300 to 4,000 metric tons of 
active ingredient per year in 2004 through 
2009. Insecticide use against Chagas disease in 
the American region was substantially reduced 
after 2003 [Supplemental Material, Table 4 
(http://dx.doi.org/10.1289/ehp.1104340)].
Discussion
The reported data had exceptional global cov-
erage of human populations living in countries 
with vector control programs. Nevertheless, 
some responding countries may have lacked 
capacity for monitoring and reporting on all 
uses of vector control insecticides. In particu-
lar, dengue control is generally less resourced 
and structured than is malaria control (Gubler 
2002). Hence, inadequate access to data by 
the national level could have resulted in under-
reporting of insecticide use for dengue in some 
countries. Countries with recent programs on 
West Nile virus control should be considered 
for inclusion in future studies.
A striking finding was the dominance 
of pyrethroids for use in vector control, in 
terms of the area treated, particularly given 
probable underreporting of use for dengue. 
The contribution of pyrethroids to insecticide 
use for vector control increased steadily from 
2004. Most apparent was the sharp increase in 
pyrethroid use in 2009 in the African region, 
which was predominantly due to indoor 
residual spraying against malaria. However, 
it is important to note that our estimates 
do not account for pyrethroids used in the 
manufacture of LNs. In 2009, 88 million 
LNs were distributed in Africa and 13 million 
were distributed outside Africa; in 2010, 
145 million LNs were distributed in Africa and 
20 million outside Africa (Milliner J, personal 
communication, 2011). Assuming equal global 
shares in the number of LNs manufactured 
using each of three pyrethroids, and assuming 
average doses of 1 g/m2 for permethrin, 
0.07 g/m2 for deltamethrin, and 0.23 g/m2 
for α-cypermethrin and 16 m2 of fabric per 
net (WHO Pesticide Evaluation Scheme, 
unpublished data, 2011), we estimate that 
700 and 1,100 metric tons of pyrethroids were 
used to manufacture LNs globally in 2009 and 
2010, respectively. Consequently, the inclusion 
of LNs would have more than doubled our 
2009 estimate for pyrethroid use in vector 
control globally.
Concurrent use of pyrethroids for indoor 
residual spraying and LNs could increase 
the pressure for resistance development in 
vector populations (WHO 2011a). In 2009, 
19 countries in the African region reported 
using pyrethroids for indoor residual spraying 
against malaria. These countries included 
Ethiopia, Kenya, Liberia, Madagascar, Mali, 
Mozambique, Nigeria, Rwanda, Senegal, 
Tanzania, and Uganda, all of which have 
high coverage rates of LNs for malaria control 
(WHO 2010a). Hence, the increasing trend in 
pyrethroid use for indoor residual spraying may 
not be consistent with the need to preserve the 
effectiveness of LNs (WHO 2011a).
According to a recent report from the 
U.S. President’s Malaria Initiative (PMI 
2011a), in 2010 and 2011 Ethiopia, Liberia, 
Mali, Senegal, and Uganda switched partly 
or entirely from pyrethroids to carbamates 
(i.e., bendiocarb) for indoor residual spraying 
because of evidence of resistance against 
pyrethroids. This move may help preserve 
susceptibility of vectors to the pyrethroids used 
in LNs. However, evidence of resistance to 
bendiocarb has emerged from several countries 
in Africa (Hunt et al. 2010, 2011; Ranson et al. 
2009; Vezenegho et al. 2009).
Pyrethroids also were used against 
several diseases outside of the African region, 
including malaria, dengue, leishmaniasis, and 
Chagas disease in the American region and 
malaria and dengue in the Western Pacific 
region. In addition, LNs were distributed in 
both regions (WHO 2010a). Thus, there is a 
need to harmonize and coordinate insecticide 
resistance management between disease-specific 
programs in all regions, particularly given that 
the intensity of use of pyrethroids, in terms of 
Figure 1. Relative global share of the four classes of insecticides in the annual use for vector control, 
expressed in terms of spray utility (recommended surface or area covered by a given amount of active 
ingredient).
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Figure 2. Trends in the annual use of organochlorines and pyrethroids for vector control in the African 
region (metric tons of active ingredients).
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grams per capita, was almost eight times greater 
in the American region than in any other region.
Experience from agriculture and public 
health indicates that resistance management 
strategies are most effective when implemented 
at the onset of control programs to prevent the 
selection of resistance, rather than responding 
after resistance genes have already spread 
[Insecticide Resistance Action Committee 
(IRAC) 2011]. Australian cotton production 
provides a good example where effective 
resistance management necessitated the 
restriction of pyrethroid use on all crops to a 
fixed period of 42 days per year, a voluntary 
strategy that was adopted by almost 100% of 
growers (Andow et al. 2008; Forrester 1990). 
This example underscores the rigorous effort 
that may be required to prevent the spread of 
resistance genes.
In areas where resistance genes have 
already spread, immediate implementation of 
resistance management is required to preserve 
the effectiveness of available tools (WHO 
2011a), notably LNs. Options include using 
insecticides with different modes of action in 
rotation, as mixed formulations, or in mosaic 
patterns (IRAC 2011), but these options are 
limited by the few distinct modes of action 
offered by currently available vector control 
insecticides (Nauen 2007; Zaim and Guillet 
2002), by the availability of only one class of 
insecticides for the manufacture of LNs, and 
by the fact that LNs can remain efficacious for 
several years. More cost-effective formulations 
of existing insecticide molecules are being 
developed and could be marketable soon, but 
insecticides with novel modes of action will 
take much longer to develop (Butler 2011; 
Hemingway et al. 2006). The use of bacterial 
larvicides against malaria and dengue signals 
a diversification of vector control methods in 
some countries.
Insecticide use in other sectors, particularly 
agriculture, also contributes to resistance 
development in disease vectors (Lines 1988). 
Global insecticide use in 2007 has been 
estimated at 404,000 metric tons of active 
ingredient (Grube et al. 2011), with vector 
control insecticides constituting < 2% of this 
total. Hence, it would be prudent to coordinate 
an insecticide resistance management strategy 
between different sectors using insecticides.
Two patterns in the use of DDT for vector 
control are apparent since the Stockholm 
Convention entered into force in 2004. 
India continued to dominate the global use 
of DDT but showed a modest decline in 
use after 2005. In the African region, DDT 
use increased sharply until 2008, along with 
efforts to expand programs on indoor residual 
spraying. In 2009, use of DDT in the African 
region decreased, primarily due to changes in 
three countries: Ethiopia reduced the use of 
DDT after evidence of widespread insecticide 
resistance (PMI 2011b), Mozambique used up 
remaining stocks after a change in policy away 
from DDT (Abilio et al. 2011), and in Uganda 
a high court decision prohibited the use of 
DDT in 2008, although the case was later 
dismissed. The coming years will show whether 
the recent drop in use of DDT in Africa is part 
of a trend. New evidence points to resistance 
to DDT and pyrethroids in parts of Zambia, a 
country that has been using DDT for malaria 
control (Chanda et al. 2011).
A long-term strategy to reduce the 
selection pressure for insecticide resistance 
and reliance on persistent organic pollutants 
such as DDT is offered by integrated vector 
management, including increased collaboration 
among disease control programs, intersectoral 
coordination, improved evidence-based 
targeting, use of multiple vector control 
methods (including nonchemical methods) 
wherever practicable, judicious application 
of insecticides, and implementation of good 
pesticide management practices (WHO 2012). 
Integrated vector management was modeled 
on the positive experience with integrated pest 
management in agriculture.
Conclusions
The use of vector control insecticides was 
dominated by organochlorines (i.e., DDT) in 
terms of quantity applied (71% of total), and 
by pyrethroids in terms of surface area treated 
(81% of total).
The global use of DDT has not changed 
substantially since the Stockholm Convention 
entered into force. India, by far the largest user 
of DDT, showed a modest decline in use after 
2005, but use increased sharply in the African 
region until 2008 because of expanding pro-
grams on indoor residual spraying. The increase 
in pyrethroid use has major implications for the 
spread of insecticide resistance with potential to 
reduce the efficacy of LNs, a tool that depends 
solely on the action of pyrethroids. In the 
African, American, and Western Pacific regions, 
pyrethroids were used against several diseases, 
and in the American region, the use inten-
sity per capita was much higher than in other 
regions. Insecticide resistance management 
strategies should be coordinated among disease-
specific programs and donor-supported projects 
and with the agriculture sector. Integrated vec-
tor management, as a rational decision-making 
process, offers a long-term approach to reduce 
selection pressure for insecticide resistance and 
to ensure the judicious use of insecticides.
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